# Terlipressin

## Glypressin inj 0.1mg/mL, 8.5mL

| TAH Drug Code      | [IGLYP8](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IGLYP8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bleeding oesophageal varices, and hepatorenal syndrome (HRS) Type 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | [Bleeding oesophageal varices] Initial: 2 ampoules IV Q4H, maintained until bleeding has been controlled but up to a maximum of 48 hours. Body weight <50kg : 1 ampoule IV Q4H; maintenance dosage (if necessary), 1 ampoule IV Q4H for a maximum of 3 days. Duration of treatment must not exceed 5 days. [Type 1 hepatorenal syndrome] 3-4 ampoules IV Q24H, divided as 3 or 4 administrations. In the absence of any reduction of the serum creatinine after 3 days of treatment, cessation of treatment is advised. In the other cases, treatment is to be pursued until the obtaining either of a serum creatinine < 130 Î¼mol/litre or of a drop of at least 30 % in the serum creatinine with respect to the value measured at the time of diagnosis of hepatorenal syndrome. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Pregnancy. Hypersensitivity to terlipressin or to any of the excipients. In patients with septic shock with a low cardiac output terlipressin should not be used. Contraindicated in patients with current or recent (within the last 3 months) ischaemic cardiovascular disease. Hypoxia or worsening respiratory symptoms. Ongoing coronary, peripheral or mesenteric ischemia .                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common: Abdominal pain (19.5%), Diarrhea (13%), Nausea (16%), Dyspnea (12.5%), Headache. Serious: Ischemia, Respiratory failure (15.5%), Hyponatremia, Bradycardia (5%), Hypervolemia (9%), Sepsis (6%), Pleural effusion (6%), Intestinal necrosis, Gangrene of skin and/or subcutaneous tissues, Skin necrosis, Acute myocardial infarction, Cardiogenic shock, Left ventricular dysfunction (including left ventricular failure, left ventricular posterior wall hypokinesia, and takotsubo cardiomyopathy), Prolonged QT interval on ECG (including torsades de pointes), Supraventricular tachycardia, Ventricular dysfunction, Rhabdomyolysis.                                                                                                                                |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/terlipressin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

